Bromazepam shortage — BE supply status & alternatives

Bromazepam

ATC N05BA08

🇦🇺 AUST R 52269 · Pharmaco Australia Ltd

In supply · Australia

Bromazepam Almus

In supply · 🇦🇺 Australia · short in🇮🇹 IT🇧🇪 BE🇳🇱 NL

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$9.33DPMQ A$33.82details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)

Brand names	Bromazepam Almus

ATC level 5	N05BA08

ATC level 4	N05BA

Therapeutic category	Auto-created by Agenzia Italiana del Farmaco — Carenze scraper

Controlled substance	No

Marketing-authorisation holders	Pharmaco Australia Ltd, APOTEX INC, TEVA CANADA LIMITED, GENPHARM ULC +5 more

Registrations on file	17

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$9.33

AEMP

Dispensed (DPMQ)

A$33.82

incl. fees

Pack

bromazepam 3 mg tablet, 30

Source: PBSEffective July 2026 · AUD

Other markets

🇫🇷 FR

€1.71

Retail price

🇪🇸 ES

€1.09

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇮🇹

Italy

AIFA · 23h ago

Medium

🇧🇪

FAMHP · 1d ago

Medium

🇳🇱

Netherlands

CBG-MEB · 1d ago

Medium

🇪🇸

Spain

AEMPS · 1mo ago

Resolved

Verified timeline regulator events

🇮🇹 1 July 2026

Shortage resolved

🇳🇱 17 June 2026

medium reported

🇳🇱 20 May 2026

medium reported

🇳🇱 28 Apr 2026

medium reported

🇧🇪 3 Apr 2026

medium reported

🇮🇹 1 Apr 2026

medium reported

Sources official regulators

🇮🇹

AIFA

verified 23h ago

verify ↗

🇧🇪

FAMHP

verified 1d ago

verify ↗

🇳🇱

CBG-MEB

verified 1d ago

verify ↗

🇪🇸

AEMPS

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders17 registrations · 9 MA holders

Product	Strength	Form	Market	MA holder	Status
LEXOTAN bromazepam	3mg	—	🇦🇺 AU	Pharmaco Australia Ltd	Active
LEXOTAN bromazepam	6mg	—	🇦🇺 AU	Pharmaco Australia Ltd	Active
Apo-Bromazepam	—	tablet	🇨🇦 CA	APOTEX INC	Active
Teva-Bromazepam	—	tablet	🇨🇦 CA	TEVA CANADA LIMITED	Active
BROMAZEPAM	—	tablet	🇨🇦 CA	APOTEX INC	Active
Gen-Bromazepam - Tab	3MG	tablet	🇨🇦 CA	GENPHARM ULC	Active
Gen-Bromazepam - Tab	6MG	tablet	🇨🇦 CA	GENPHARM ULC	Active
Alti-Bromazepam	6MG	tablet	🇨🇦 CA	ALTIMED PHARMA INC.	Active
Alti-Bromazepam	3MG	tablet	🇨🇦 CA	ALTIMED PHARMA INC.	Active
Alti-Bromazepam	1.5MG	tablet	🇨🇦 CA	ALTIMED PHARMA INC.	Active
Mylan-Bromazepam	—	tablet	🇨🇦 CA	MYLAN PHARMACEUTICALS ULC	Active
Bromazepam-1.5 - Tab	1.5MG	tablet	🇨🇦 CA	PRO DOC LIMITEE	Active
Bromazepam-3 - Tab	3MG	tablet	🇨🇦 CA	PRO DOC LIMITEE	Cancelled
Bromazepam-6 - Tab	6MG	tablet	🇨🇦 CA	PRO DOC LIMITEE	Cancelled
Penta-Bromazepam	—	tablet	🇨🇦 CA	PENTAPHARM LTD.	Cancelled

+2 more registrations on file

Mederti Drug Report

Generated 3 July 2026 · Australia market · 4 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.